Sign in
4

Changes in Ownership

NEKTAR THERAPEUTICS Filed Acc 0001209191-17-060974

SVP & Chief Operating Officer sold 15,910 shares at $37.78 ($601,080)

  • SVP & Chief Operating Officer acquired 25,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I In the form
Nicholson John SVP & Chief Operating Officer 2017-11-13 Option exercise +25,000 $9.24 $231,000 249,066 D
Nicholson John SVP & Chief Operating Officer 2017-11-13 Sale −15,910 $37.78 $601,080 233,156 D
Derivatives
Nicholson John SVP & Chief Operating Officer 2017-11-13 Option exercise · Stock Option −25,000 0 D
Open-market sales · 15,910 sh · avg $37.78 · $601,080
Loading xslF345X03/doc4.xml…